These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34529153)

  • 1. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases.
    Papasavvas I; de Courten C; Herbort CP
    J Ophthalmic Inflamm Infect; 2021 Sep; 11(1):28. PubMed ID: 34529153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpetic Eye Disease After SARS-CoV-2 Vaccination: A CDC-VAERS Database Analysis.
    Singh RB; Parmar UPS; Ichhpujani P; Jeng BH; Jhanji V
    Cornea; 2023 Jun; 42(6):731-738. PubMed ID: 36706232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report.
    Awaly ZWN
    Clin Exp Vaccine Res; 2023 Jan; 12(1):82-84. PubMed ID: 36844689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.
    Martinez-Reviejo R; Tejada S; Adebanjo GAR; Chello C; Machado MC; Parisella FR; Campins M; Tammaro A; Rello J
    Eur J Intern Med; 2022 Oct; 104():73-79. PubMed ID: 35931613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.
    Maldonado MD; Romero-Aibar J
    Brain Behav Immun Health; 2021 Dec; 18():100381. PubMed ID: 34746880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients].
    Amblard MA; Costantini E; Hayek G; Ricaud X
    J Fr Ophtalmol; 2022 Nov; 45(9):1000-1003. PubMed ID: 36155145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of Varicella-Zoster Virus Keratitis After SARS-CoV-2 Vaccination.
    Ryu KJ; Kim DH
    Cornea; 2022 May; 41(5):649-650. PubMed ID: 35383620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpetic Eye Disease Following the SARS-CoV-2 Vaccinations.
    Cohen S; Olshaker H; Fischer N; Vishnevskia-Dai V; Hagin D; Rosenblatt A; Zur D; Habot-Wilner Z
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1151-1162. PubMed ID: 35914308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated optic neuritis with a concurrent abnormal trigeminal nucleus on imaging: case report of a rare complication of herpes zoster ophthalmicus.
    Vanikieti K; Poonyathalang A; Jindahra P; Cheecharoen P; Patputtipong P; Padungkiatsagul T
    BMC Neurol; 2018 Oct; 18(1):165. PubMed ID: 30286736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination.
    Jabbour S; Shekhawat NS; Chen A; Woreta FA
    Cornea; 2021 Feb; 40(2):248-250. PubMed ID: 32947398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes Zoster Ophthalmicus After COVID-19 Vaccination: Chance Occurrence or More?
    Rehman O; Arya SK; Jha UP; Nayyar S; Goel I
    Cornea; 2022 Feb; 41(2):254-256. PubMed ID: 34690265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pole-to-pole involvement of varicella zoster virus reactivation following COVID-19 vaccination.
    Mahendradas P; Parmar Y; Mishra SB; Patil A; Kawali A; Sanjay S; Shetty B
    Indian J Ophthalmol; 2023 May; 71(5):2001-2007. PubMed ID: 37203073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes Zoster Ophthalmicus Review and Prevention.
    Davis AR; Sheppard J
    Eye Contact Lens; 2019 Sep; 45(5):286-291. PubMed ID: 30844951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine.
    Riazuddin M; Jefri MH; Butt MI; Alsalamah HI; Ali Sheikh ANM
    Cureus; 2023 Jan; 15(1):e33962. PubMed ID: 36820114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipsilateral Zoster Ophthalmicus Post COVID-19 Vaccine in Healthy Young Adults.
    Thimmanagari K; Veeraballi S; Roach D; Al Omour B; Slim J
    Cureus; 2021 Jul; 13(7):e16725. PubMed ID: 34471577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abducens Nerve Palsy as a Complication of Herpes Zoster Ophthalmicus: A Case Report.
    Al-Sadi A; Abdulgayoom M; Jawarneh I; Al-Warqi A
    Cureus; 2022 Mar; 14(3):e22920. PubMed ID: 35399428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster ophthalmicus: declining age at presentation.
    Davies EC; Pavan-Langston D; Chodosh J
    Br J Ophthalmol; 2016 Mar; 100(3):312-4. PubMed ID: 26178905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
    Vallianou NG; Tsilingiris D; Karampela I; Liu J; Dalamaga M
    Metabol Open; 2022 Mar; 13():100171. PubMed ID: 35169692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.